Pages that link to "Q61117287"
Jump to navigation
Jump to search
The following pages link to Lars Farde (Q61117287):
Displaying 50 items.
- Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals (Q21136367) (← links)
- Application of cross-species PET imaging to assess neurotransmitter release in brain (Q26865012) (← links)
- The serotonin system and spiritual experiences (Q28181386) (← links)
- The correlative triad among aging, dopamine, and cognition: current status and future prospects (Q28257099) (← links)
- A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain (Q29400289) (← links)
- Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach (Q30512685) (← links)
- Modeling of PET data in CNS drug discovery and development (Q30623699) (← links)
- Performance evaluation of the small-animal nanoScan PET/MRI system. (Q30664136) (← links)
- Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data (Q30940742) (← links)
- Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study (Q33465817) (← links)
- Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning (Q33841939) (← links)
- The International Journal of Neuropsychopharmacology (Q33945980) (← links)
- Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method (Q34072978) (← links)
- Effects of amphetamine on the human brain opioid system--a positron emission tomography study. (Q34296653) (← links)
- Changes in cortical dopamine D1 receptor binding associated with cognitive training. (Q34938660) (← links)
- Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain (Q35179039) (← links)
- Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder. (Q36132042) (← links)
- QTc interval prolongation and antipsychotic drug treatments: focus on sertindole (Q36166468) (← links)
- Support for limited brain availability of tyrosine in patients with schizophrenia. (Q36171412) (← links)
- Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio (Q36267484) (← links)
- Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates (Q36287874) (← links)
- A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates (Q36368922) (← links)
- Using positron emission tomography to facilitate CNS drug development (Q36470266) (← links)
- Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients (Q36662808) (← links)
- [11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors (Q36865865) (← links)
- Arterial input function derived from pairwise correlations between PET-image voxels (Q36994317) (← links)
- Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628. (Q37220469) (← links)
- Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184. (Q37392615) (← links)
- Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats (Q37462057) (← links)
- Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain (Q37560665) (← links)
- Antipsychotic occupancy of dopamine receptors in schizophrenia (Q37818511) (← links)
- GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans (Q38383138) (← links)
- 5-HT1B receptor imaging and cognition: a positron emission tomography study in control subjects and Parkinson's disease patients (Q38412475) (← links)
- Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data (Q38667002) (← links)
- Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects (Q38775836) (← links)
- Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390. (Q38831944) (← links)
- Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676. (Q38842931) (← links)
- The immune response of the human brain to abdominal surgery (Q38933080) (← links)
- Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study (Q39005986) (← links)
- Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. (Q39029124) (← links)
- Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain. (Q39123290) (← links)
- Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging. (Q39394319) (← links)
- Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. (Q39705255) (← links)
- Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans (Q40012224) (← links)
- [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain (Q40099443) (← links)
- Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study (Q40319442) (← links)
- Utilization of radioligands in schizophrenia research (Q40428235) (← links)
- Chemical brain anatomy in schizophrenia (Q40473365) (← links)
- Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. (Q40614739) (← links)
- Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain (Q40792145) (← links)